Erratum: Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy (Virchows Archiv DOI: 10.1007/s00428-008-0653-2);Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy

Virchows Archiv

Volumn 453, Issue 4, 2008, Pages 329-338

  Valbuena, Carmen ^a,b   Carvalho, Elísio ^a   Bustorff, Manuela ^a   Ganhão, Mariana ^a   Relvas, Sandra ^a   Nogueira, Rosete ^c   Carneiro, Fátima ^a,b,d   Oliveira, João Paulo ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Fabry disease; Heterozygous females; Kidney pathology

Indexed keywords

GLYCOSPHINGOLIPID;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CASE REPORT; CELL TYPE; ELECTRON MICROSCOPY; FABRY DISEASE; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; LIPID STORAGE; MICROSCOPY; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA;

EID: 52649095922     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0779-x     Document Type: Erratum

References (60)

1. Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease. 8th edn. McGraw Hill, New York, pp 3733-3774
2. Desnick RJ, Wasserstein MP, Banikazemi M (2001) Fabry disease (α-Galactosidase A deficiency): renal involvement and enzyme replacement therapy. In: Schieppati A, Daina E, Sessa A, Remuzzi G (eds) Rare kidney diseases (contributions to nephrology, vol 136). Karger, Basel, pp 174-192
3. RJ Desnick R Brady J Barranger 2003 Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy Ann Intern Med 138 338 346
4. A Ortiz JP Oliveira S Waldek 2008 Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy Nephrol Dial Transplant 23 1600 1607
5. MF Lyon 1962 Sex chromatin and gene action in the mammalian X chromosome Am J Hum Genet 14 135 418
6. PB Deegan AF Baehner M-Á Barba Romero 2006 Natural history of Fabry disease in females in the Fabry outcome survey J Med Genet 43 347 352
7. WR Wilcox JP Oliveira RJ Hopkin 2008 Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry Mol Genet Metab 93 112 128
8. KD [tmp] MacDermot A Holmes AH Miners 2001 Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females [Letter] J Med Genet 38 769 775
9. R Thadhani M Wolf ML West 2002 Patients with Fabry disease on dialysis in the United States Kidney Int 61 249 255
10. M-C Gubler G Lenoir J-P Grünfeld 1978 Early renal changes in hemizygous and heterozygous patients with Fabry's disease Kidney Int 13 223 235
11. A Sessa A Tosoni M Nebuloni 2002 Renal ultrastructural findings in Anderson-Fabry disease J Nephrol 15 109 112
12. J Alroy S Sabnis JB Kopp 2002 Renal pathology in Fabry disease J Am Soc Nephrol 13 S134 S138
13. EG Fischer MJ Moore DJ Lager 2006 Fabry disease: a morphologic study of 11 cases Mod Path 19 1295 1301
14. A Sessa M Meroni G Battini 2003 Renal involvement in Anderson-Fabry disease J Nephrol 16 310 313
15. SM Meehan T Junsanto JJ Rydel RJ Desnick 2004 Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications Am J Kidney Dis 43 164 171
16. DG Warnock 2005 Fabry disease: diagnosis and management, with emphasis on the renal manifestations Curr Opin Nephrol Hypertens 14 87 95
17. A Sessa M Meroni G Battini 2003 Evolution of renal pathology in Fabry disease Acta Paediatr Suppl 443 6 8
18. BF Palmer 2007 Proteinuria as a therapeutic target in patients with chronic kidney disease Am J Nephrol 27 287 293
19. AWM Pompen M Ruiter HJG Wyers 1947 Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports Acta Med Scand 128 234 255
20. JR Colley DL Miller MSR Hutt 1958 The renal lesion in angiokeratoma corporis diffusum Brit M J 1 1266 1268
21. JE Bethune PL Landrigan CD Chipman 1961 Angiokeratoma corporis diffusum universale (Fabry's disease) in two brothers New Engl J Med 264 1280 1285
22. EW Henry CR Rally 1963 The renal lesion in angiokeratoma corporis diffusum (Fabry's disease) Can Med Assoc J 89 206 213
23. WP Groot 1964 Angiokeratoma corporis diffusum Fabry (Thesaurismosis hereditaria Ruiter-Pompen-Wyers) Dermatologica 128 321 349
24. MW Hartley RE Miller HJ Dempsey JF Carroll 1964 Dysphospholipidosis in Fabry's disease: a light and electron microscopic study Ala J Med Sci 1 361 367
25. CD Burda PR Winder 1967 Angiokeratoma corporis diffusum universale (Fabry's disease) in female subjects Am J Med 42 293 301
26. MH Branton R Schiffmann SG Sabnis 2002 Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course Medicine (Baltimore) 81 122 138
27. JP Oliveira 2007 Staging of Fabry disease using renal biopsies Clin Ther 29 Suppl A S15 S16
28. AV Chobanian GL Bakris HR Black 2003 Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206 1252
29. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41
30. AD Rule TS Larson EJ Bergstralh 2004 Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease Ann Intern Med 141 929 937
31. G Vervoort HL Willems JFM Wetzels 2002 Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant 17 1909 1913
32. EA Gehan SL George 1970 Estimation of human body surface area from height and weight Cancer Chemother Rep 54 225 235
33. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification Am J Kidney Dis 39 Suppl.1 S1 S266
34. RJ Desnick KY Allen SJ Desnick 1973 Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes J Lab Clin Med 81 157 171
35. DA Wiseman R Hawkins LM Numerow KJ Taub 1990 Percutaneous renal biopsy utilizing real time, ultrasonic guidance and a semiautomated biopsy device Kidney Int 38 347 349
36. WL Whittier SM Korbet 2004 Renal biopsy: update Curr Opin Nephrol Hypertens 13 661 665
37. PN Furness 2000 ACP best practice No 160: renal biopsy specimens J Clin Pathol 53 433 438
38. PD Walker T Cavallo SM Bonsib Ad Hoc Committee on Renal Biopsy Guidelines of the Renal Pathology Society 2004 Practice guidelines for the renal biopsy Mod Path 17 1555 1563
39. Sternberg SS (ed) (1992) Histology for pathologists. Raven, New York
40. G Remuzzi J Grinyò P Ruggenenti 1999 Early experience with dual kidney transplantation in adults using expanded donor criteria J Am Soc Nephrol 10 2591 2598
41. C Meaney LC Blanch CP Morris 1994 A nonsense mutation (R220X) in the α-galactosidase A gene detected in a female carrier of Fabry disease Hum Mol Genet 3 1019 1020
42. CM Eng N Guffon WR Wilcox 2001 Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease N Engl J Med 345 9 16
43. R Schiffmann JB Kopp HA Austin 3rd 2001 Enzyme replacement therapy in Fabry disease: a randomized controlled trial JAMA 285 2743 2749
44. BL Thurberg H Rennke RB Colvin 2002 Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy Kidney Int 62 1933 1946
45. E Svarstad L Bostad O Kaarbøe 2005 Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease Clin Nephrol 63 394 401
46. AR Chade A Lerman OL Lerman 2005 Kidney in early atherosclerosis Hypertension 45 1042 1049
47. ERSP Caetano R Zatz LB Saldanha JN Praxedes 2001 Hypertensive nephrosclerosis as a relevant cause of chronic renal failure Hypertension 38 171 176
48. Olson JL, Schwartz MM (1998) The nephrotic syndrome: minimal change disease, focal segmental glomerulosclerosis, and miscellaneous causes. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 5th edn. Lippincott-Raven, Philadelphia, pp 187-257
49. Pirani CL (1994) Evaluation of kidney biopsy specimens. In: Tisher CG, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 85-115
50. A Tosoni M Nebuloni P Zerbi 2005 Ultrastructural study of renal involvement in two females with Anderson-Fabry disease Ultrastruct Pathol 29 203 207
51. T Faraggiana J Churg E Grishman 1981 Light- and electron-microscopic histochemistry of Fabry's disease Am J Pathol 103 247 262
52. W Kriz N Gretz KV Lemley 1998 Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54 687 697
53. W Kriz KV Lemley 1999 The role of the podocyte in glomerulosclerosis Curr Opin Nephrol Hypertens 8 489 497
54. P Mundel SJ Shankland 2002 Podocyte biology and response to injury J Am Soc Nephrol 13 3005 3015
55. I Ichikawa J Ma M Motojima T Matsusaka 2005 Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis Curr Opin Nephrol Hypertens 14 205 210
56. O Kawamura H Sakuraba K Itoh 1997 Subclinical Fabry's disease occurring in the context of IgA nephropathy Clin Nephrol 47 71 75
57. A Yoshida K Morozumi A Takeda 1994 Fabry-like laminated myelin body associated with IgA nephropathy Nippon Jinzo Gakkai Shi 36 1303 1307
58. C Whybra A Schwarting J Kriegsmann 2006 IgA nephropathy in two adolescent sisters heterozygous for Fabry disease Pediatr Nephrol 21 1251 1256
59. F Breunig F Weidemann J Strotmann 2006 Clinical benefit of enzyme replacement therapy in Fabry disease Kidney Int 69 1216 1221
60. R Waldherr M Rambausek WD Duncker E Ritz 1989 Frequency of mesangial IgA deposits in a non-selected autopsy series Nephrol Dial Transplant 4 943 946